Current Oncology Reports

Papers
(The TQCC of Current Oncology Reports is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer174
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review171
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers135
Brain Prehabilitation for Oncologic Surgery126
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors91
NRG1 Fusions: The New Kid on the Block88
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications70
Management of Upper Tract Urothelial Carcinoma63
The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain60
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances58
New Developments in VHL-Associated Neuroendocrine Neoplasms54
Immunotherapy in Biliary Tract Cancers: Where Are We?47
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review47
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas47
Surgical Management of Melanoma: Advances and Updates44
Fatty Acid Metabolism and Cancer Immunotherapy43
Treatment of Metastatic Melanoma in the Elderly43
Management of In-Transit Metastases42
AXL Inhibitors: Status of Clinical Development41
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites41
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications40
Head and Neck Mucosal Melanoma: Where Are We Now?38
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients36
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients35
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan35
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting34
Surgical Stress and Cancer Progression: New Findings and Future Perspectives34
Current Trends and Challenges of Microbiome Research in Prostate Cancer33
Cellular Therapy in NSCLC: Between Myth and Reality33
The Microbiome in Advanced Melanoma: Where Are We Now?33
The Difficult Airway in Patients with Cancer33
Engineered T Cells: CAR T Cell Therapy and Beyond32
Anti-PD-1: When to Stop Treatment32
An Overview of Angiogenesis in Bladder Cancer32
Targeting the PI3K Pathway in Gynecologic Malignancies31
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?31
What Is the Status of Immunotherapy in Neuroendocrine Neoplasms?31
Appendiceal Neuroendocrine Neoplasms: an Update for 202330
Cancer Pain Management—New Therapies30
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations30
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review30
Current Status of Stem Cell Transplant in Treatment of Testicular Germ Cell Tumors29
Proton Therapy in The Treatment of Head And Neck Cancers- Review28
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours27
Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy27
CAR-T Therapies in Solid Tumors: Opportunities and Challenges26
Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations26
Pitfalls and Successes in Trials in Older Transplant Patients with Hematologic Malignancies26
Critical Review of the Current Evidence on Sentinel Node Biopsy in Oral Cancer25
Use of Circulating Tumor DNA to Guide Decision-making in Adjuvant Colon Cancer25
Treatments on the Horizon: Breast Cancer Patients with Central Nervous System Metastases25
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing25
Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions24
Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer–Related Lymphedema: a Systematic Review24
Evolving Treatment Approaches to Mucosal Melanoma24
Surgery for Recurrent Epithelial Ovarian Cancer24
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question23
Geographical Disparities in Colorectal Cancer in Canada: A Review23
Helping Patients Understand and Cope with BRCA Mutations22
A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)22
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma22
Diagnostic Accuracy of Liquid Biopsy for Oral Potentially Malignant Disorders and Head and Neck Cancer: an Overview of Systematic Reviews22
Development of Effective Siglec-9 Antibodies Against Cancer22
Current Management of Neuroendocrine Tumour Liver Metastases22
Vascular Inflammation, Cancer, and Cardiovascular Diseases22
Cardioprotection for Anti-HER2 Therapy: Considerations for Primary Prevention and Use in Mildly Reduced Left Ventricular Ejection Fraction21
Small Cell and Other Rare Histologic Types of Cervical Cancer21
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials21
The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging20
Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity20
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?20
Controversies in the Treatment of Adolescents and Young Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia20
Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets20
Current Diagnostic Tools for Breast Cancer-Related Lymphedema19
Rehabilitation in Advanced Cancer Patients with Bone Metastases and Neural Compromise: Current Status and Future Directions19
Elderly Rectal Cancer: An Updated Review19
Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic19
Management of Peripheral T-cell Lymphomas and the Role of Transplant19
Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy18
Ependymoma: Evaluation and Management Updates18
Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review18
History of Leukemia, Revisited18
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer18
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers17
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights17
Current Status on Management of Primary Plasma Cell Leukemia17
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review17
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis17
Statins for Cardiac and Vascular Protection During and After Cancer Therapy17
Intratumoral Immunotherapy: Is It Ready for Prime Time?17
Multimodality Therapies for Localized Prostate Cancer17
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy17
Richter’s Transformation17
Immunological Insights into Opioid-Free Anaesthesia in Oncological Surgery: A Scoping Review17
Epidemiology of Cancer in Older Adults: A Systematic Review17
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade17
Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge16
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours16
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment16
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives16
Return to Intended Oncological Therapy: State of the Art and Perspectives16
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions15
Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies15
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?15
CDK4/6 inhibitors: The Devil is in the Detail15
Bystander effect of antibody–drug conjugates: fact or fiction?15
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer15
Racial Disparities in Breast Cancer: from Detection to Treatment15
Viral and Clinical Oncology of Head and Neck Cancers15
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment15
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development15
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma15
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas15
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL15
All-Cause Mortality Risk Prediction in Older Adults with Cancer: Practical Approaches and Limitations14
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer14
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway14
Advances in Treatment of Waldenström Macroglobulinemia14
Cardio-Oncology in Childhood: State of the Art14
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer14
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine14
CAR T-cell Therapy for Central Nervous System Lymphoma14
Clinicopathological Review of Micropapillary Urothelial Carcinoma14
Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer14
Lymphatic Interventions in the Cancer Patient14
Correction: Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science14
0.11554718017578